Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
138.00
+7.50 (5.75%)
May 29, 2026, 1:30 PM CST
TPEX:3218 Market Cap
TPEX:3218 has a market cap or net worth of 11.69 billion as of May 29, 2026. Its market cap has decreased by -21.14% in one year.
Market Cap
11.69B
Enterprise Value
10.55B
Revenue
4.17B
Ranking
n/a
PE Ratio
12.32
Stock Price
138.00
Market Cap Chart
Since November 3, 2008, TPEX:3218's market cap has increased from 1.01B to 11.69B, an increase of 1,062.89%. That is a compound annual growth rate of 14.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 11.69B | -5.48% |
| Dec 31, 2025 | 12.37B | -27.00% |
| Dec 31, 2024 | 16.94B | -27.80% |
| Dec 29, 2023 | 23.47B | -1.63% |
| Dec 30, 2022 | 23.86B | 10.75% |
| Dec 30, 2021 | 21.54B | 18.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 345.61B |
| Caliway Biopharmaceuticals | 156.41B |
| Lotus Pharmaceutical | 51.25B |
| Heron Neutron Medical | 50.09B |
| Visco Vision | 12.16B |
| Foresee Pharmaceuticals | 12.13B |
| Excelsior Medical | 12.03B |
| Handa Pharmaceuticals | 11.92B |